Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Return on Assets (2016 - 2025)

Historic Return on Assets for Aytu Biopharma (AYTU) over the last 17 years, with Q4 2025 value amounting to 0.0%.

  • Aytu Biopharma's Return on Assets rose 100.0% to 0.0% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.0%, marking a year-over-year increase of 100.0%. This contributed to the annual value of 0.01% for FY2025, which is 300.0% up from last year.
  • Latest data reveals that Aytu Biopharma reported Return on Assets of 0.0% as of Q4 2025, which was up 100.0% from 0.0% recorded in Q3 2025.
  • Aytu Biopharma's Return on Assets' 5-year high stood at 0.0% during Q2 2025, with a 5-year trough of 0.71% in Q2 2022.
  • In the last 5 years, Aytu Biopharma's Return on Assets had a median value of 0.12% in 2023 and averaged 0.21%.
  • As far as peak fluctuations go, Aytu Biopharma's Return on Assets plummeted by -4900bps in 2022, and later surged by 5900bps in 2023.
  • Aytu Biopharma's Return on Assets (Quarter) stood at 0.37% in 2021, then tumbled by -42bps to 0.53% in 2022, then surged by 84bps to 0.09% in 2023, then surged by 87bps to 0.01% in 2024, then skyrocketed by 108bps to 0.0% in 2025.
  • Its Return on Assets was 0.0% in Q4 2025, compared to 0.0% in Q3 2025 and 0.0% in Q2 2025.